At Neuphoria Therapeutics, we are dedicated to pioneering breakthrough therapies that address the complex needs of individuals affected by neuropsychiatric disorders. By focusing on novel approaches and advancing scientific understanding, we aim to deliver medicines that offer lasting relief and hope for a brighter, healthier future.
Available treatments such as Selective Serotonin Reuptake Inhibitors (SSRIs) and benzodiazepines, offer some benefits to patients but can sometimes result in more issues than they resolve.
BNC210, a first-of-its-kind, well-tolerated anti-anxiety medication, is designed to restore balance in brain chemistry, providing rapid relief from anxiety symptoms without the common pitfalls of sedation, cognitive impairment, or addiction.
Effective across a range of anxiety disorders, including PTSD, social anxiety disorder (SAD) and more
Fast-acting proprietary tablet formulation can be taken “as-needed” or regularly, allowing for customizable treatment.
Delivers relief without sedation, addiction potential, or mental fog.
Targets neurotransmitter balance in a novel way, filling critical gaps in current mental health treatments.
Discover how our groundbreaking technology is transforming mental health—contact us today to learn more.